RNS Number : 4316I
Seymour Pierce Ltd
11 March 2010
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader Seymour Pierce Limited
Company dealt in Fulcrum Pharma plc
Class of relevant security to which the dealings Ordinary 1p Shares
being disclosed relate(Note 1)
Date of dealing 10.03.10
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities Highest price paid(Note 3) Lowest price paid(Note 3)
purchased
50,000 0.02560 GBP 0.02560 GBP
Total number of securities Highest price received(Note 3) Lowest price received(Note 3)
sold
200,000 0.02700 GBP 0.02700 GBP
(b) Derivatives transactions (other than options)
Product name, Long/short(Note 4) Number of Price per unit(Note 3)
e.g. CFD securities(Note 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g. American, Expiry Option money
e.g. call option purchasing, varying to which the option price European etc. date paid/received per
etc. relates(Note 5) unit(Note 3)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per
unit(Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of any
relevant securities under any option referred to on this form or relating to
the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
Date of disclosure 11.03.10
Contact name Lynette Patterson
Telephone number 020 7107 8033
Name of offeree/offeror with which connected Fulcrum Pharma plc
Nature of connection(Note 6) Nomad and Broker
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMKKDDNKBKDFND
